Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2026-04-28 16:23:58 ET · period of report 2026-04-24 · accession 0001051578-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-28 16:23 | 2026-04-24 | TARS | PYOTT DAVID E I | Dir | M - OptEx | — | +1,383 | 1,383 | New | — |
| D | 2026-04-28 16:23 | 2026-04-24 | TARS | PYOTT DAVID E I | Dir | M - OptEx | $0.00 | -1,383 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-24 | M | A | 1,383 | — | 1,383 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2026-04-24 | M | D | 1,383 | $0.00 | 0 | D | — · — to — | 1,383 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service. (F3) The RSUs vested in full on April 24, 2026, subject to the Reporting Person's continuous service. |